Avoro Capital Advisors — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Whitehawkwhitehawktx.cominMay 2026 · $87.5M
Whitehawk Therapeutics develops antibody-drug conjugate (ADC) therapeutics through intentional clinical development.
BiotechHealthtech
Dave Lennon, PhD(President & CEO)Dave Lennon(President & CEO)in
Co-investorsInvus
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.